(Q35063200)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12576163%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

review article

1 reference

title

Current limitations of antiepileptic drug therapy: a conference review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12576163%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12576163%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

author name string

C L P Deckers

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12576163%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

P Genton

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12576163%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

D Schmidt

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12576163%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12576163%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12576163%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12576163%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12576163%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

page(s)

1-17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12576163%20AND%20SRC:MED&resulttype=core&format=json

Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group.

18 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Seizure-inducing effects of antiepileptic drugs: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Exacerbation of juvenile myoclonic epilepsy with lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

The star systems: overview and use in determining antiepileptic drug choice

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Exacerbation of seizures in children by carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

The efficacy of carbamazepine combinations in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Incidence of drug-induced aggravation in benign epilepsy with centrotemporal spikes

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Place of polytherapy in the early treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

"Baltic" myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Gabapentin and vigabatrin increase GABA in the human neocortical slice

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

When antiepileptic drugs aggravate epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Summary. Aggravation of seizures by antiepileptic drugs: what to do in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Early identification of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Epilepsy after the first drug fails: substitution or add-on?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Effectiveness of first antiepileptic drug.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

The mechanisms of action of commonly used antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Seizures induced or aggravated by anticonvulsants

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Absence seizures aggravated by valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Development of myoclonus in patients with partial epilepsy during treatment with vigabatrin: an electroencephalographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Alertness and incidence of seizures in patients with Lennox-Gastaut syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Antiepileptic drugs as a cause of worsening seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

The clinical impact of new antiepileptic drugs after a decade of use in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Alternative single anticonvulsant drug therapy for refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

New strategies for the identification of drugs to prevent the development or progression of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Topiramate in refractory epilepsy: a prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Tonic Status Epilepticus precipitated by Intravenous Benzodiazepine in Five Patients with Lennox-Gastaut Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900257-7

7 January 2021

10.1016/S0920-1211(02)00257-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12576163%20AND%20SRC:MED&resulttype=core&format=json

18 December 2019

1 reference